Acute exposure to silica nanoparticles aggravate airway inflammation: different effects according to surface characteristics

Experimental and Molecular Medicine

Volumn 47, Issue 7, 2015, Pages

  Park, Hye Jung ^a   Sohn, Jung Ho ^a,b   Kim, Yoon Ju ^a   Park, Yoon Hee ^a   Han, Heejae ^a   Park, Kyung Hee ^a   Lee, Kangtaek ^c   Choi, Hoon ^c   Um, Kiju ^c   Choi, In Hong ^d   Park, Jung Won ^a   Lee, Jae Hyun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Yonsei University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN DERIVATIVE; MACROGOL DERIVATIVE; NANOPARTICLE; OVALBUMIN; SILICON DIOXIDE;

ANIMAL; ASTHMA; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; FEMALE; INFLAMMATION; LUNG; PATHOLOGY; SURFACE PROPERTY;

ANIMALS; ASTHMA; FEMALE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKINS; LUNG; MICE, INBRED BALB C; NANOPARTICLES; OVALBUMIN; POLYETHYLENE GLYCOLS; SILICON DIOXIDE; SURFACE PROPERTIES;

EID: 85018237363     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/EMM.2015.50     Document Type: Article

References (35)

1. Roco MC. Nanotechnology: convergence with modern biology and medi-cine. Curr Opin Biotechnol 2003; 14: 337–346.
2. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed Engl 2007; 46: 7548–7558.
3. Carino IS, Pasqua L, Testa F, Aiello R, Puoci F, Iemma F et al. Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Deliv 2007; 14: 491–495.
4. Maynard AD. Nanotechnology: the next big thing, or much ado about nothing? Ann Occup Hyg 2007; 51: 1–12.
5. Nemmar A, Al-Salam S, Zia S, Yasin J, Al Husseni I, Ali BH. Diesel exhaust particles in the lung aggravate experimental acute renal failure. Toxicol Sci 2010; 113: 267–277.
6. Inoue K, Koike E, Takano H. Comprehensive analysis of elastase-induced pulmonary emphysema in mice: effects of ambient existing particulate matters. Int Immunopharmacol 2010; 10: 1380–1389.
7. Inoue K, Takano H, Yanagisawa R, Ichinose T, Shimada A, Yoshikawa T. Pulmonary exposure to diesel exhaust particles induces airway inflammation and cytokine expression in NC/Nga mice. Arch Toxicol 2005; 79: 595–599.
8. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K. Silica nanoparticles as hepatotoxicants. Eur J Pharm Biopharm 2009; 72: 496–501.
9. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K. Histological analysis of 70-nm silica particles-induced chronic toxicity in mice. Eur J Pharm Biopharm 2009; 72: 626–629.
10. Chen W, Zhang Q, Kaplan BL, Baker GL, Kaminski NE. Induced T cell cytokine production is enhanced by engineered nanoparticles. Nanotox-icology 2014; 8(Suppl 1): 11–23.
11. Kuhlbusch TA, Asbach C, Fissan H, Gohler D, Stintz M. Nanoparticle exposure at nanotechnology workplaces: a review. Part Fibre Toxicol 2011; 8: 22.
12. Eisen EA, Costello S, Chevrier J, Picciotto S. Epidemiologic challenges for studies of occupational exposure to engineered nanoparticles; a commen-tary. J Occup Environ Med 2011; 53: S57–S61.
13. Inoue K, Takano H. Aggravating impact of nanoparticles on immune-mediated pulmonary inflammation. ScientificWorldJournal 2011; 11: 382–390.
14. Sanya RE, Kirenga BJ, Worodria W, Okot-Nwang M. Risk factors for asthma exacerbation in patients presenting to an emergency unit of a national referral hospital in Kampala, Uganda. Afr Health Sci 2014; 14: 707–715.
15. Saraya T, Kurai D, Ishii H, Ito A, Sasaki Y, Niwa S et al. Epidemiology of virus-induced asthma exacerbations: with special reference to the role of human rhinovirus. Front Microbiol 2014; 5: 226.
16. Esposito S, Tenconi R, Lelii M, Preti V, Nazzari E, Consolo S et al. Possible molecular mechanisms linking air pollution and asthma in children. BMC Pulm Med 2014; 14: 31.
17. Dombu C, Carpentier R, Betbeder D. Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells. Biomaterials 2012; 33: 9117–9126.
18. Chau E, Galloway JF, Nelson A, Breysse PN, Wirtz D, Searson PC et al. Effect of modifying quantum dot surface charge on airway epithelial cell uptake in vitro. Nanotoxicology 2013; 7: 1143–1151.
19. Marzaioli V, Aguilar-Pimentel JA, Weichenmeier I, Luxenhofer G, Wiemann M, Landsiedel R et al. Surface modifications of silica nanoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties. Int J Nanomedicine 2014; 9: 2815–2832.
20. Cullinan P, Reid P. Pneumoconiosis. Prim Care Respir J 2013; 22: 249–252.
21. Laney AS, Weissman DN. The classic pneumoconioses: new epidemiologi-cal and laboratory observations. Clin Chest Med 2012; 33: 745–758.
22. Steenland K, Ward E. Silica: a lung carcinogen. CA Cancer J Clin 2014; 64: 63–69.
23. Caplan A. Rheumatoid disease and pneumoconiosis (Caplan’s syndrome). Proc R Soc Med 1959; 52: 1111–1113.
24. Yamazaki S, Yoshiike F, Hirai K, Kakegawa T, Ikeda M, Nagata A et al. Silica-associated systemic lupus erythematosus in an elderly man. Intern Med 2007; 46: 1867–1871.
25. Suh WH, Suslick KS, Stucky GD, Suh YH. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol 2009; 87: 133–170.
26. Li FF, Zhang XX, Guo SY, Gan Y, Li J. [Preliminary study on pH-sensitive lipid bilayer-coated mesoporous silica nanoparticles as a novel drug carrier for antitumor drug]. YaoXueXueBao2013; 48: 291–297.
27. Luo GF, Chen WH, Liu Y, Lei Q, Zhuo RX, Zhang XZ. Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide. Sci Rep 2014; 4: 6064.
28. Andreani T, de Souza AL, Kiill CP, Lorenzon EN, Fangueiro JF, Calpena AC et al. Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery. Int J Pharm 2014; 473: 627–635.
29. Han B, Guo J, Abrahaley T, Qin L, Wang L, Zheng Y et al. Adverse effect of nano-silicon dioxide on lung function of rats with or without ovalbumin immunization. PLoS One 2011; 6: e17236.
30. Brandenberger C, Rowley NL, Jackson-Humbles DN, Zhang Q, Bramble LA, Lewandowski RP et al. Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice. Part Fibre Toxicol 2013; 10: 26.
31. Neunkirchner A, Leb-Reichl VM, Schmetterer KG, Mutschlechner S, Kueng HJ, Haiderer D et al. Human TCR transgenic Bet v 1-specific Th1 cells suppress the effector function of Bet v 1-specific Th2 cells. JImmunol 2011; 187: 4077–4087.
32. He Q, Zhang Z, Gao F, Li Y, Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 2011; 7: 271–280.
33. Docter D, Bantz C, Westmeier D, Galla HJ, Wang Q, Kirkpatrick JC et al. The protein corona protects against size-and dose-dependent toxicity of amorphous silica nanoparticles. Beilstein J Nanotechnol 2014; 5: 1380–1392.
34. Brown DM, Kanase N, Gaiser B, Johnston H, Stone V. Inflammation and gene expression in the rat lung after instillation of silica nanoparticles: effect of size, dispersion medium and particle surface charge. Toxicol Lett 2013.
35. Skuland T, Ovrevik J, Lag M, Refsnes M. Role of size and surface area for pro-inflammatory responses to silica nanoparticles in epithelial lung cells: importance of exposure conditions. Toxicol In Vitro 2014; 28: 146–155.